Zenas BioPharma sets price range for $200 million initial public offering

Date:

September 6, 2024

Zenas BioPharma Inc., a Waltham, Mass.-based developer of immunology-based therapies, on Friday said it plans to offer 11.76 million shares of common stock at an estimated price range of $16 to $18 in its upcoming initial public offering.

Source link

Google faces provisional antitrust charges in UK for ‘self-preferencing’ its ad exchange

You Won't Believe How Much High-Income Earners Save for Retirement

Alexandra Williams

Alexandra Williams is a writer and editor. Angeles. She writes about politics, art, and culture for LinkDaddy News.

Zenas BioPharma sets price range for $200 million initial public offering

Recent posts

Super Micro needs a new CEO before its AI advantage erodes

Olive Garden parent Darden’s Q1 earnings fall short after ‘significant’ drop in traffic in July

Gold gets a boost from expected Fed interest-rate cuts, new focus on jobs

South Korea’s brief martial-law showdown: What U.S. investors need to know

DexCom shares tumble nearly 40% after company cuts sales forecast

JPMorgan’s top strategist Marko Kolanovic is leaving after missing stocks’ historic rally

Hugo Boss shares sink as company becomes latest fashion seller to cut guidance

Cost of shorting Carl Icahn company’s stock has spiked since billionaire’s SEC settlement

Retiree healthcare costs jump almost 5% to $165,000 — more than double the 2002 rate

‘DJT’ stock has seen ‘aggressive’ selling by retail investors leading into election

Hedge-fund manager who could be Trump Treasury secretary says tariffs can be negotiated lower

Israel’s attack on Iran spares oil, nuclear facilities and probably markets too

These two crypto funds may be compelling ways to bet on a Trump election win

AI chip startup Cerebras files for IPO, in market dominated by Nvidia

Wall Street is going all-in on election betting markets. What you need to know.

Related articles

Cocoa’s the best-performing commodity in 2024 — and even beat bitcoin. What’s next.

As the wealthy keep spending, here’s why the middle class is in for a tough 2025

How this Treasury-market dynamic could lead to the next big leg lower in stocks

As Teamsters go on strike, Amazon and its investors are trying to shrug it off

Oil may ‘collapse’ below $50 a barrel in 2025 if this perfect storm hits the market

New investigation rips Amazon’s safety record. That’s not slowing the tech giant’s stock.

U.S. oil prices drop nearly 1% on weak Chinese retail-sales data

UnitedHealth Group CEO says healthcare needs fixing. Start with these 3 problems in claims and patient costs, experts say.

Company

Follow us